Key Metrics
CiteScore 

8.9
Eigenfactor 

0.001 - 0.005
H-Index 

49
Impact Factor 

5 - 10
SJR 

Q1Hepatology

SNIP 

1.69
Recommended pre-submission checks
Powered by 

Topics Covered on Clinical and Molecular Hepatology
Clinical and Molecular Hepatology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | KOREAN ASSOC STUDY LIVER |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | KRW 42000 |
| Publication Time | 10 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Clinical and Molecular Hepatology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical and Molecular Hepatology
Beyond the Single Model: Critical Considerations for Translating HCC Triplet Immunotherapy from Bench to Bedside.
- 26 Dec 2025
- Clinical and molecular hepatology
Comment on the expert consensus on treatment approaches for achieving functional cure in chronic hepatitis B.
- 26 Dec 2025
- Clinical and molecular hepatology
Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.
- 26 Dec 2025
- Clinical and molecular hepatology
MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLD.
- 26 Dec 2025
- Clinical and molecular hepatology
Correspondence to editorial "Mechanistic Insights into a Noncanonical RAB25-GCN1 axis in ALD: on RAB25/GCN1 signaling promotes ER stress to mediate alcohol-associated liver disease progression".
- 23 Dec 2025
- Clinical and molecular hepatology
Correspondence to the editorial "Berberine and the gut microbiota - A novel treatment strategy for cholestatic liver disease".
- 23 Dec 2025
- Clinical and molecular hepatology
Beyond the Single Model: Critical Considerations for Translating HCC Triplet Immunotherapy from Bench to Bedside.
- 26 Dec 2025
- Clinical and molecular hepatology
Comment on the expert consensus on treatment approaches for achieving functional cure in chronic hepatitis B.
- 26 Dec 2025
- Clinical and molecular hepatology
Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.
- 26 Dec 2025
- Clinical and molecular hepatology
MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLD.
- 26 Dec 2025
- Clinical and molecular hepatology
Correspondence to editorial "Mechanistic Insights into a Noncanonical RAB25-GCN1 axis in ALD: on RAB25/GCN1 signaling promotes ER stress to mediate alcohol-associated liver disease progression".
- 23 Dec 2025
- Clinical and molecular hepatology
Correspondence to the editorial "Berberine and the gut microbiota - A novel treatment strategy for cholestatic liver disease".
- 23 Dec 2025
- Clinical and molecular hepatology